Argenx
ARGX
#529
Rank
โ‚น3.385 T
Marketcap
โ‚น55,716
Share price
-0.46%
Change (1 day)
67.97%
Change (1 year)
Argenx is a Dutch company that develops antibody therapies to fight autoimmune diseases and cancer.

EPS for Argenx (ARGX)

EPS in 2023 (TTM): -โ‚น343.30

According to Argenx 's latest financial reports the company's current EPS (TTM) is -โ‚น359.64. In 2022 the company made an earnings per share (EPS) of -โ‚น1,134.

EPS history for Argenx from 2022 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-โ‚น343.30-69.73%
2022-โ‚น1,134